1-2 of 2
Ameena Manzoor
Close
Sort by
Journal Articles

Updated Results of the Phase II Trial of Inotuzumab Ozogamicin (INO) Combined with Mini-Hyper-CVD As Salvage Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Rita Assi, MD, Hagop M. Kantarjian, MD, Rita Khouri, Farhad Ravandi, MBBS, Partow Kebriaei, MD, Nicholas J Short, MD, Deborah A Thomas, MD, Guillermo Garcia-Manero, MD, Richard E Champlin, MD, Tapan Kadia, MD, Jorge E. Cortes, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Zeev Estrov, MD, Koichi Takahashi, MD, Koji Sasaki, MD, Jovitta Jacob, RN, Ameena Manzoor, Rebecca Garris, Msc, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2597.
https://doi.org/10.1182/blood.V130.Suppl_1.2597.2597
Published: 2017
Journal Articles

A Phase I/II Study of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Nicholas J Short, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Xuelin Huang, PhD, Nitin Jain, MD, Naval Daver, MD, Deborah A Thomas, MD, Naveen Pemmaraju, MD, Rita Khouri, Joseph David Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Yesid Alvarado, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Jorge E. Cortes, MD, Christopher B Benton, MD, Gautam Borthakur, MD, Jan A. Burger, MD PhD, Maro Ohanian, DO, William G Wierda, MD PhD, Zeev Estrov, MD, Steven Kornblau, MD, Courtney D. DiNardo, MDMSc, Alessandra Ferrajoli, MD, Jovitta Jacob, RN, Ameena Manzoor, Rebecca Garris, Msc, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2576.
https://doi.org/10.1182/blood.V130.Suppl_1.2576.2576
Published: 2017